Would you like to help reduce risk, prevent harm and improve experience of anti-D treatment in pregnancy?
Following the February 2026 update to NICE QS138 Statement 2 on tranexamic acid (TXA), the QS138 Quality Insights quality improvement tool has been updated to reflect the broadened eligibility criteria.
National Transfusion Practitioners Network
Healthcare professionals and other NBTC stakeholders may wish to note an update from Jehovah’s Witnesses regarding individual decisions on the acceptance and donation of major blood components.